Average Co-Inventor Count = 8.05
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (23 from 329 patents)
2. Eli Lilly and Company (6 from 4,447 patents)
3. Mirati Therapeutics, Inc. (3 from 38 patents)
4. Wisconsin Alumni Research Foundation (2 from 4,127 patents)
5. Celgene Corporation (2 from 550 patents)
31 patents:
1. 12187721 - Protein tyrosine phosphatase inhibitors
2. 11884664 - Protein tyrosine phosphatase inhibitors
3. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
4. 11634417 - Protein tyrosine phosphatase inhibitors
5. 11267812 - KRAS G12C inhibitors
6. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases
7. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
8. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
9. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
10. 10633381 - KRas G12C inhibitors
11. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
12. 10125134 - KRas G12C inhibitors
13. 9079890 - Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives
14. 8933077 - Glucokinase activators
15. 8883828 - 2-aminopyridine analogs as glucokinase activators